Linked Data API

Show Search Form

Search Results

226318
registered interest false more like this
date less than 2015-03-10more like thismore than 2015-03-10
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Levodopa more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, pursuant to the Answer of 2 March 2015 to Question 224941, what the precise recommendation made by the Clinical Reference Group referred to in that Answer was; whether that recommendation related to (a) in year or (b) ongoing routine commissioning; and if he will make a statement. more like this
tabling member constituency Sutton and Cheam remove filter
tabling member printed
Paul Burstow more like this
uin 227005 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-17more like thismore than 2015-03-17
answer text <p>NHS England has advised that its Neuroscience Clinical Reference Group’s recommendation was to approve the clinical policy to support the routine commissioning of levodopa-carpidopa intestinal gel for advanced Parkinson’s disease and to go out to full public consultation.</p><p> </p><p> </p><p> </p><p>The recommendation related to an in year commissioning decision.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-03-17T15:53:34.2Zmore like thismore than 2015-03-17T15:53:34.2Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
204
label Biography information for Paul Burstow more like this